Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis Duration in Liver Transplant
NCT02717273Phase 3Completed
- Sponsor
- University of Virginia
- Start
- Mar 2009
- Primary completion
- Oct 2015
- Modality
- Irreversible Covalent Inhibitors
01
Overview
A Phase 3 trial of piperacillin + tazobactam in surgical site infection (SSI), sponsored by University of Virginia. Started Mar 2009; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02717273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02717273.